Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)

被引:20
作者
Kim, Chang Seong [1 ]
Bae, Eun Hui [1 ]
Ma, Seong Kwon [1 ]
Han, Seung Hyeok [2 ]
Lee, Kyu-Beck [3 ]
Lee, Joongyub [4 ,5 ]
Oh, Kook-Hwan [6 ]
Chae, Dong Wan [7 ]
Kim, Soo Wan [1 ]
机构
[1] Chonnam Natl Univ, Dept Internal Med, Sch Med, Gwangju, South Korea
[2] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Nephrol, Sch Med, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Seoul, South Korea
[6] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[7] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Chronic Kidney Disease; Bone Diseases; Vascular Calcification; Korean; FIBROBLAST GROWTH FACTOR-23; VITAMIN-D; SECONDARY HYPERPARATHYROIDISM; PREDIALYSIS PATIENTS; PARATHYROID-HORMONE; NATIONAL-HEALTH; FRACTURE RISK; DENSITY; METABOLISM; PHOSPHATE;
D O I
10.3346/jkms.2017.32.2.240
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examined the characteristics of biochemical parameters, bone diseases, and vascular calcification in Korean patients with chronic kidney disease (CKD) not yet on dialysis. Serum levels of fibroblast growth factor 23 (FGF23), intact parathyroid hormone (iPTH), 25-hydroxyvitamin D3 (25D), and 1,25-dihydroxyvitamin D3 (1,25D); lumbar spine, total hip, and femur neck bone mineral densities; and brachial-to-ankle pulse wave velocity (baPWV) representing vascular calcification were measured at baseline for 2,238 CKD patients in the KoreaN Cohort Study for Outcomes in Patients With CKD (KNOW-CKD). Increases in serum FGF23 and iPTH preceded changes in serum calcium and phosphate, similar to Western populations. However, the 25D and 1,25D levels decreased earlier than serum FGF23 or iPTH increased, with a decreased estimated glomerular filtration rate (eGFR) in Korean CKD patients. Vitamin D deficiency occurred in 76.7% of patients with CKD stage 1. Bone mineral densities were lowest in CKD stage 5 (lumbar spine, -0.64 +/- 1.67; total hip, -0.49 +/- 1.21; femur neck, -1.02 +/- 1.25). Osteoporosis was more prevalent in patients with higher CKD stages. The mean baPWV, abdominal aortic calcification (AAC), and coronary calcium score also increased, with declined eGFR. In conclusion, a decline in serum vitamin D levels was observed in early CKD stages before significant increases of FGF23 and iPTH in the Korean CKD population compared with that in Western populations. Increased bone disease and vascular calcification occurred in early-stage CKD.
引用
收藏
页码:240 / 248
页数:9
相关论文
共 40 条
[11]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305
[12]   Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease [J].
Gutierrez, O ;
Isakova, T ;
Rhee, E ;
Shah, A ;
Holmes, J ;
Collerone, G ;
Jüppner, H ;
Wolf, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :2205-2215
[13]   Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis [J].
Gutierrez, Orlando M. ;
Mannstadt, Michael ;
Isakova, Tamara ;
Rauh-Hain, Jose Alejandro ;
Tamez, Hector ;
Shah, Anand ;
Smith, Kelsey ;
Lee, Hang ;
Thadhani, Ravi ;
Juppner, Harald ;
Wolf, Myles .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06) :584-592
[14]   Fibroblast Growth Factor 23 and Disordered Vitamin D Metabolism in Chronic Kidney Disease: Updating the "Trade-off" Hypothesis [J].
Gutierrez, Orlando M. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (09) :1710-1716
[15]   Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease [J].
Hu, Ming Chang ;
Shi, Mingjun ;
Zhang, Jianning ;
Quinones, Henry ;
Griffith, Carolyn ;
Kuro-o, Makoto ;
Moe, Orson W. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (01) :124-136
[16]   Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease [J].
Isakova, Tamara ;
Wahl, Patricia ;
Vargas, Gabriela S. ;
Gutierrez, Orlando M. ;
Scialla, Julia ;
Xie, Huiliang ;
Appleby, Dina ;
Nessel, Lisa ;
Bellovich, Keith ;
Chen, Jing ;
Hamm, Lee ;
Gadegbeku, Crystal ;
Horwitz, Edward ;
Townsend, Raymond R. ;
Anderson, Cheryl A. M. ;
Lash, James P. ;
Hsu, Chi-yuan ;
Leonard, Mary B. ;
Wolf, Myles .
KIDNEY INTERNATIONAL, 2011, 79 (12) :1370-1378
[17]   Cortical PQCT measures are associated with fractures in dialysis patients [J].
Jamal, SA ;
Gilbert, J ;
Gordon, C ;
Bauer, DC .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (04) :543-548
[18]   Racial Differences in Markers of Mineral Metabolism in Advanced Chronic Kidney Disease [J].
Jovanovich, Anna ;
Chonchol, Michel ;
Cheung, Alfred K. ;
Kaufman, James S. ;
Greene, Tom ;
Roberts, William L. ;
Smits, Gerard ;
Kendrick, Jessica .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (04) :640-647
[19]   Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients [J].
Kanda, Eiichiro ;
Yoshida, Masayuki ;
Sasaki, Sei .
BMC NEPHROLOGY, 2012, 13
[20]   Noninvasive imaging for assessment of calcification in chronic kidney disease [J].
Karohl, Cristina ;
D'Marco Gascon, Luis ;
Raggi, Paolo .
NATURE REVIEWS NEPHROLOGY, 2011, 7 (10) :567-577